-
Amino acid sequence of the active site peptide of bovine intestinal 5'-nucleotide phosphodiesterase and identification of the active site residue as threonine.
We report here the identification of the amino acid residue which forms the covalent intermediate in the catalytic mechanism of bovine intestinal 5'-nucleotide phosphodiesterase and the sequence of the neighboring amino acids. The active site of 5'-nucleotide phosphodiesterase was labeled using thymidine 5'-[alpha-32P]triphosphate as substrate. A single labeled cyanogen bromide peptide was isolated using reversed-phase high performance liquid chromatography. After subdigestion with endoproteinase Lys-C and chymotrypsin, the entire amino acid sequence of the 60-residue active site peptide was obtained using automated Edman degradation. All of the radioactivity of the active site peptide was localized to a hexapeptide with sequence Thr-Phe-Pro-Asn-His-Tyr. Phosphoamino acid analysis of this peptide indicated that the labeled residue was threonine. We are not aware of any other enzymes in which threonine is phosphorylated as a covalent intermediate in the catalytic mechanism.
PMID: 2989287 [PubMed - indexed for MEDLINE]
-
Cited by 6 PubMed Central articles
-
Rat liver nucleotide pyrophosphatase/phosphodiesterase is an efficient adenylyl transferase.
Ribeiro JM, López-Gómez J, Vergeles JM, Costas MJ, García-Díaz M, Fernández A, Flores A, Cameselle JC.
Biochem J. 2000 Feb 15; 346 Pt 1:25-31.
[Biochem J. 2000]
-
Fowlpox virus encodes nonessential homologs of cellular alpha-SNAP, PC-1, and an orphan human homolog of a secreted nematode protein.
Laidlaw SM, Anwar MA, Thomas W, Green P, Shaw K, Skinner MA.
J Virol. 1998 Aug; 72(8):6742-51.
[J Virol. 1998]
-
Expression of the murine plasma cell nucleotide pyrophosphohydrolase PC-1 is shared by human liver, bone, and cartilage cells. Regulation of PC-1 expression in osteosarcoma cells by transforming growth factor-beta.
Huang R, Rosenbach M, Vaughn R, Provvedini D, Rebbe N, Hickman S, Goding J, Terkeltaub R.
J Clin Invest. 1994 Aug; 94(2):560-7.
[J Clin Invest. 1994]
- » See all...